SERUM LEVELS OF FAS/APO-1 AND FAS LIGAND (FASL) IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

被引：0
|
作者：
Panafidina, T. A. [1 ]
Sokhova, M. A. [1 ]
Popkova, T. V. [1 ]
Cherkasova, M. A. [1 ]
Novikov, A. A. [1 ]
Aleksandrova, E. N. [1 ]
Nasonov, E. L. [1 ]
机构：
[1] Nasonova Res Inst Rheumatol, Moscow, Russia
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2016年 / 75卷
关键词：
D O I：
10.1136/annrheumdis-2016-eular.4053
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0516
引用
收藏
页码：1082 / 1082
页数：1
相关论文
共 50 条
  • [1] Associations of serum soluble Fas and Fas ligand (FasL) with outcomes in systemic lupus erythematosus
    Vincent, Fabien B.
    Kandane-Rathnayake, Rangi
    Koelmeyer, Rachel
    Harris, James
    Hoi, Alberta Y.
    Mackay, Fabienne
    Morand, Eric F.
    LUPUS SCIENCE & MEDICINE, 2020, 7 (01):
  • [2] Association of Fas/APO-1 gene polymorphism with systemic lupus erythematosus in Japanese
    Horiuchi, T
    Nishizaka, H
    Yasunaga, S
    Higuchi, M
    Tsukamoto, H
    Hayashi, K
    Nagasawa, K
    RHEUMATOLOGY, 1999, 38 (06) : 516 - 520
  • [3] Expression of Fas (APO-1/CD95) and Fas ligand (FasL) in human neuroblastoma
    Gross, N
    Balmas, K
    Brognara, CB
    Tschopp, J
    MEDICAL AND PEDIATRIC ONCOLOGY, 2001, 36 (01): : 111 - 114
  • [4] Evaluation of a new Apo-1/Fas promoter polymorphism in rheumatoid arthritis and systemic lupus erythematosus patients
    Huang, QR
    Danis, V
    Lassere, M
    Edmonds, J
    Manolios, N
    RHEUMATOLOGY, 1999, 38 (07) : 645 - 651
  • [5] Levels of soluble Fas/APO-1/CD95 in systemic lupus erythematosus and juvenile rheumatoid arthritis
    Knipping, E
    Krammer, PH
    Onel, KB
    Lehman, TJA
    Mysler, E
    Elkon, KB
    ARTHRITIS AND RHEUMATISM, 1995, 38 (12): : 1735 - 1737
  • [6] Serum levels of soluble Fas/APO-1 receptor are increased in systemic sclerosis
    Wetzig, T
    Petri, JB
    Mittag, M
    Haustein, UF
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 1998, 290 (04) : 187 - 190
  • [7] Serum levels of soluble Fas/APO-1 receptor are increased in systemic sclerosis
    T. Wetzig
    J. B. Petri
    M. Mittag
    U.-F. Haustein
    Archives of Dermatological Research, 1998, 290 : 187 - 190
  • [8] Lack of Correlation between Apo-1/Fas Promoter Polymorphism and Susceptibility to Systemic Lupus Erythematosus
    Radzi, Azizah Mohd
    Hun, Kuak Sai
    Kong, Norella
    Yahaya, Normaznah
    INTERNATIONAL MEDICAL JOURNAL, 2008, 15 (04): : 257 - 259
  • [9] Correlation between Serum Levels of Soluble Fas (CD95/Apo-1) with Disease Activity in Systemic Lupus Erythematosus Patients in Khorasan, Iran
    Sahebari, Maryam
    Hatef, Mohammad Reza
    Rezaieyazdi, Zahra
    Abbasi, Mahnaz
    Abbasi, Bita
    Mahmoudi, Mahmoud
    ARCHIVES OF IRANIAN MEDICINE, 2010, 13 (02) : 135 - 142
  • [10] Increased Fas ligand and soluble Fas ligand in patients with systemic lupus erythematosus.
    Min, JK
    Kim, JY
    Kim, WU
    Kim, SI
    Yoo, WH
    Hong, YS
    Park, SH
    Cho, CS
    Kim, HY
    ARTHRITIS AND RHEUMATISM, 1997, 40 (09): : 1647 - 1647
12345